Financing - September 14, 2016
Catching the eye of international investors
The NLSDays Super Session about “What’s hot in the eyes of international investors?” brought up the importance about having solid science, new and innovative technology and being able to explain this. Alison Hilton from the DNM emphasized the importance of proving yourself from a health economic standpoint and in terms of their interests and she […]
CRO - September 13, 2016
Immuneed secures SEK 4.3M in financing
Immuneed secures SEK 4.3M in seed financing to further develop its immuno-oncology cancer vaccine candidate and grow its human whole-blood loop service for detection of acute immune related side effects of biopharmaceuticals. After Immuneed’s establishment in 2014 and early funding from Bio-X (Uppsala Bio/VINNOVA) and the Dutch Technology Foundation STW, Immuneed has secures SEK 4.3M […]
Financing - September 13, 2016
Promimic raises SEK 23.8 million
The Swedish biomaterials company Promimic has secured SEK 23.8 million (US$3.2 million) in a new share issue to finance the establishment of its commercial operations in the US. Chalmers Ventures participated as a new investor alongside existing investors Karolinska Development and Almi Invest. The new operation will be based in Austin, Texas and will be […]
Financing - September 4, 2016
Finnish industry reports record-high investment volume
Finnish Industry Investment half-year report 2016 shows a record-high investment volume – €100 million to finance company growth. “Our investment volume in the first half of 2016 was record-high: we made new investments and commitments amounting to over €100 million. Significant events include commitments to international venture capital funds such as EQT Ventures and Northzone […]
Financing - August 17, 2016
NeoDynamics raises 22.5 MSEK
Swedish NeoDynamic has issued shares with a value of 22.5 MSEK to Boai NKY Pharmaceuticals Ltd, a publicly traded company based in Jiaozuo, China. NeoDynamics welcomes a strong owner with good contacts into the Chinese market. The company has developed a new technology and needle design supporting the development within the breast cancer field and […]
Financing - July 5, 2016
17 million SEK to R&D in Umeå
For the second time, Umeå Biotech Incubator (UBI) has been granted funding from the Family Erling-Persson Foundation, this time the sum is 17 million SEK. Results from previous allocations are positive, the incubator’s external capital to start-up companies has increased with over 200 percent between 2014 and 2015. The collaboration is now prolonged for another […]
